DrugPatentWatch Database Preview
Drugs in Development Information for Nitrendipine
What is the development status for investigational drug Nitrendipine?
Nitrendipine is an investigational drug.
There have been 6 clinical trials for Nitrendipine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Muscle Hypertonia, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are Katholieke Universiteit Leuven, Merck KGaA, and University of Erlangen-Nürnberg Medical School.
Summary for Nitrendipine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,477 |
| WIPO Patent Applications | 2,161 |
| Japanese Patent Applications | 12 |
| Clinical Trial Progress | Phase 3 (2009-11-01) |
| Vendors | 77 |
Recent Clinical Trials for Nitrendipine
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor | Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Treatment of Hypertension in Tibetan Adult Population | West China Hospital | Phase 4 |
| Sympathetic Nerve Activity in Renal Failure | University of Erlangen-Nürnberg Medical School | Phase 4 |
Clinical Trial Summary for Nitrendipine
Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine
US Patents for Nitrendipine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
